Single Dose Azithromycin to Prevent Cholera in Children
Status:
Not yet recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
This study aims to determine whether single-dose azithromycin is effective in preventing
cholera in children who are at extremely high risk of infection. The study will also
determine the effect of this intervention on the development of antibiotic resistant
bacteria. The results will inform future strategies to prevent cholera in children, and
improve overall understanding of the impact of azithromycin on antibiotic resistance.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
International Centre for Diarrhoeal Disease Research, Bangladesh